Organization | Persahabatan General Hospital

Persahabatan General Hospital Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial

2007

NCT00535015

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Persahabatan Central General Hospital, Jakarta - Indonesia | Persahabatan General Hospital | Persahabatan Hospital

Active Ingredients

Drugs in Phase 4 Trials (4)

beta carotene (solatene) (1 trial)

dexamethasone (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 3 Trials (1)

ginger (1 trial)

Drugs in Phase 2 Trials (2)

piroxicam (feldene) (1 trial)

sulfamethoxazole (gantanol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anorexia (Phase 2)

Cachexia (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Enterocolitis (Phase 4)

Enterocolitis, Necrotizing (Phase 4)

Hyaline Membrane Disease (Phase 4)

Premature Birth (Phase 4)

Weight Loss (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 7